- Sickle Cell Disease Insights
- Posts
- Weekly Spotlight - 27.11.24
Weekly Spotlight - 27.11.24
CRISPR Trial Aims to Cure Genetic Cause of Sickle Cell in Patients
Community Voices |
Fill in the form if you would like to be featured in one of our weekly newsletters! Share your experiences, challenges you’ve faced and any advice that you might have for others in your community. |
Latest News |
CRISPR Trial Aims to Cure Genetic Cause of Sickle Cell in Patients |
A new CRISPR clinical trial aims to treat sickle cell disease by editing the genetic mutation that causes it. The trial uses gene editing to correct the faulty hemoglobin gene, potentially offering a permanent cure for the condition. This approach targets the root cause of sickle cell disease. |
Cyclosporin H Enhances Gene Therapy Uptake in Newborn Stem Cells for SCD Patients |
Researchers found that using cyclosporin H can increase the effectiveness of gene therapy in newborn stem cells for sickle cell disease. This approach enhances the integration of healthy genes into the cells, potentially leading to better treatment outcomes for individuals with the condition. |
Automated Red Blood Cell Exchange Improves Quality of Life for Patients, Study Finds |
Automated red blood cell exchange improves the quality of life for patients with sickle cell disease, according to both patients and scientists. This procedure helps reduce symptoms and complications, enhancing overall well-being for those affected by the condition. |
Preventable Deaths Among Sickle Cell Patients Spark Urgent Call for Change |
The column expresses frustration over the preventable deaths of sickle cell disease patients due to lack of access to proper care and resources. It highlights the need for better healthcare infrastructure, education, and advocacy to improve outcomes for those living with sickle cell disease. |

Health Spotlight’s Sickle Cell Disease is a Contentive publication in the Healthcare division